En días recientes una cuenta de @twitter que usurpaba mi nombre y mi imagen realizó declaraciones que no reflejan mi posición sobre la industria farmacéutica y/o el sistema de salud pública en México. Sectores en los que he participado activamente en los últimos 31 años.
Growth & Scale differ.
The challenge is building an organization capable of managing complexity without losing speed, accountability or strategic coherence.
My full article- The Growth Trap: When Expansion Becomes a Liability
https://t.co/CVXKRsQqdy
#PharmAdvice#BizAdvice#MBP
Most companies don’t fail in Mexico because of poor execution.
They fail because they designed the right business for the wrong ecosystem.
Market entry is an event. Sustainable expansion is a leadership discipline. You can read my article below …..
In today’s Expert Contributor, Sandra Sánchez-Oldenhage, explains that building a business is an exercise in strategic architecture, not merely market entry. Don't miss it. Out now! #MBN#MexicoBusiness
Article Link: https://t.co/Pu6LlVI9q5
Audio Link: https://t.co/IBfTfNKBEt
@MXBusinessNews Most companies don’t fail in Mexico because of poor execution.
They fail because they designed the right business for the wrong ecosystem.
Market entry is an event. Sustainable expansion is a leadership discipline.
That’s the idea behind The Architecture of Sustainable Expansion.
Many pharma companies in LATAM are growing revenue while quietly destroying value.
More SKUs.
More complexity.
Less focus.
The next pharma winners won’t have the biggest portfolios — but the most disciplined ones.
My latest article:
https://t.co/VdEU4V55Hn
Most family-owned pharma companies in LATAM don’t fail because of strategy.
They fail because they institutionalize too late.
The reality: without governance, the company may not outlive the founder.
Read my latest article:
https://t.co/SRfOxxXDqP
Most family-owned pharma companies in LATAM don’t fail because of strategy.
They fail because they institutionalize too late.
The reality: without governance, the company may not outlive the founder.
Read my latest article:
https://t.co/SRfOxxXDqP
Ya disponible mi episodio en Marathon CEO.
Liderar no es un sprint… es un maratón de propósito.
💡 El cuerpo aguanta.
💡 La mente decide.
💡 La ética te guía.
Entreno cada día para transformar.
Me preparo para el maratón, no para la fama del sprint.
https://t.co/Bx83nk6dG0
Honrada de apoyar el lanzamiento de @aurah_pharma Salud femenina pensada para cada etapa de la vida, hecha por mujeres, para mujeres.
Ciencia, empatía y bienestar consciente-sin promesas rápidas, con acompañamiento real.
🎥 Video de lanzamiento
Código SANDRAS 10% off en OneShot
Honored to be featured on Executive Session 🎙️ with Ana Dutra & Joe Mayberry discussing board evaluation, nom/gov evolution & AI oversight. Boards that use evaluation as strategy—not just compliance—are the ones that stay relevant.
🔗 Listen: https://t.co/8DKhH5zMJ3
#PharmAdvice
Boards shouldn’t just oversee - they should evolve. Evaluation isn’t a checkbox, it’s a catalyst for clarity, culture & strategic renewal. Proud to share our feature in Directors & Boards Magazine (Q3/25) 🔗 https://t.co/bzIFA433By
#BoardLeadership#StrategicBoard#PharmAdvice
AI is transforming healthcare from rural telemedicine to AI-driven clinical trials.
The key? Programs tailored to each patient segment + strong partnering- pharma leaders & Health Ministries.
#PharmAdvice
This could redefine public health
📖 Read more: https://t.co/C5WyoLvTQm
💊 Can MEXICO go from MFN price pawn to pharma power?
💥 Global shifts just opened a once-in-a-decade chance. Will we rise - or miss it ?
🚀 Read my latest article on how Mexico can lead—not lag:
👉 https://t.co/KwYFvJlsDm
#Pharma#HealthPolicy#Innovation#PharmAdvice
🌎 The future of pharma runs through LATAM.
Proud to be featured in @247BioPharma ahead of #CPHIAmericas, discussing regulatory hurdles, nearshoring potential & why LATAM is a region to watch. 📈
🔗 https://t.co/DyXOnjZypS
#Pharma#LATAMPharma#Nearshoring#PharmAdvice
Honrada de estar en el ranking de las 100 Mujeres Más Poderosas de los Negocios en México. 🌟
Gracias, Expansión, por visibilizar el liderazgo femenino. Sigamos impulsando el cambio y abriendo camino para más mujeres. 💪
#MujeresPoderosas#ExpansiónMarzo2025#PharmAdvice
Mexico’s Pharma Moment Mexico has a unique chance to lead in API production & pharma manufacturing. But time is running out! ⏳
How can Mexico turn disruption into growth? Read my latest article: https://t.co/f2O9glHkfy
#PharmAdvice#MexicoTrade#Nearshoring#API#SupplyChain
In today’s Expert Contributor, Sandra Sánchez-Oldenhage explains how Mexico can become a top pharma hub by boosting API production, nearshoring, and aligning trade policies. Don't miss it. Out now! #MBN
Article Link: https://t.co/xLkeojV4U4
Audio Link: https://t.co/aQDNRHSHxv
🚨 Is Mexico ready to lead North America's API and pharma revolution? Explore its potential and the path forward in my new article. Let’s spark the conversation!
🔗 Read it here https://t.co/NO7U5gTOn5
#PharmAdvice#SupplyChain#BizAdvice
REMEMBER the 12° Encuentro Mujeres de Éxito 2024!
📅 Nov 28th 🕒 9:00am-6:00pm (CDMX) 📍 Universidad del Pedregal, CDMX Don't miss my talk at 11:00am!
✨ Event Highlights:
•Keynote speeches
•Panel discussions
•Networking
🔗 Register https://t.co/gpdoqbMU0E
Mi experiencia c/Refacciones y Servicio ha sido patética. Pagamos un servicio urgente para reparar refrigerador y no lo hemos recibido. El trato es grosero, cuelgan al solicitar un supervisor y el técnico nunca llega. Espero cumplan #RefaccionesYServicio https://t.co/NrNld8UUp5